WO2002076436A2 - Composition de complement alimentaire - Google Patents

Composition de complement alimentaire Download PDF

Info

Publication number
WO2002076436A2
WO2002076436A2 PCT/NL2002/000197 NL0200197W WO02076436A2 WO 2002076436 A2 WO2002076436 A2 WO 2002076436A2 NL 0200197 W NL0200197 W NL 0200197W WO 02076436 A2 WO02076436 A2 WO 02076436A2
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
composition
water
dietary supplement
meg
Prior art date
Application number
PCT/NL2002/000197
Other languages
English (en)
Other versions
WO2002076436A3 (fr
Inventor
Jaap Meijer
Original Assignee
Jaap Meijer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jaap Meijer filed Critical Jaap Meijer
Priority to AU2002241408A priority Critical patent/AU2002241408A1/en
Priority to EP20020707347 priority patent/EP1469746A2/fr
Publication of WO2002076436A2 publication Critical patent/WO2002076436A2/fr
Publication of WO2002076436A3 publication Critical patent/WO2002076436A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a novel dietary supplement composition comprising vitamins, minerals and possible other health-stimulating substances, such as anti- oxidants. More in particular, the invention relates to a dietary supplement composition which is comprised of two or more different independent compositions which are to be taken at different points in time by the user in order to reach an optimum health-effect.
  • Vitamins and mineralen are essential building materials for the renewal of healthy cells and white blood corpuscles. They reject toxic substances, control the level of cholesterol, assist in the digestion and provide for optimal functioning of the skin, nerves, muscles and hormones, and strengthen the defence system.
  • Anti-oxidants are important substances which offer protection to free radicals. They are produced within the body and their concentration is increased by pollution, sunlight, alcohol and smoke of cigarettes. Too many free radicals may damage the cells in the body and may thus cause various degeneration diseases in the long term.
  • Phyto nutrients are natural nutritive substances with active parts from fruit, vegetables, grains, herbs or soya. These nutrients provide optimum protection to free radicals and at the same time they strengthen the defence system to viruses and bacterial infections. Research has revealed that the biorhythm of the human body is distinct in the uptake and removal of vitamins, minerals and anti-oxidants. This knowledge resulted in the development of a formula comprising the proper amounts for an optimum condition and a strong defence system in the body during the day and for rest and recuperation during the night. According to the invention a dietary supplement composition is now provided which both in the matter of the dosage and composition comprises a very complete formula of multivitamins, multiminerals and anti-oxidants, which is very useful for the human health promotion.
  • composition A consists essentially of water soluble vitamins
  • composition B consists essentially of fat soluble vitamins
  • Composition A is an energy-rich composition, which is comprised of water soluble vitamins, preferably supplemented with one or more minerals and other usual health- stimulating substances.
  • Composition B is a composition for recovery of the cellen in the rest phase (i.e. during the night), comprised of fat soluble vitamins, preferably supplemented with one or more minerals and other usual ingredients for this purpose.
  • composition A is taken in the morning and preferably immerdiately after breakfast and composition B is taken in the evening, i.e. about 9-17 hours after composition A.
  • composition B is taken immediately after dinner.
  • dietary supplement compositions are known both from literature and the actual practice, among which dietary supplement compositions predominantly consisting of vitamins and minerals and dietary supplement compositions, which are comprised of separate modules which are to be taken at different points in time.
  • U.S. Patents Nos. 5,948,443 and 5,976,568 disclose a total modular system of multivitamin- and mineral supplements composed of 7 modules for the promotion of public health and in particular the prevention and treatment of heart- and vascular diseases.
  • the module formulations provide nutrients in suitable amounts to the morning and evening meals to obtain maximum absorption which is inter alia caused by administering a dose in the morning and a dose in the evening.
  • composition A comprises as vitamins predominantly vitamin C, vitamin B-1 , vitamin B-2, vitamin B-3, vitamin B-5, vitamin B-6, vitamin B-12, vitamin B-15, and vitamin H
  • composition B comprises as vitamins predominantly vitamin A, provitamin A, vitamin C, vitamin D3, and vitamin K1. All vitamins are brought in a suitable form for administration.
  • Composition A further comprises one or more of the minerals chromium, potassium, copper, magnesium and manganese, in a suitable form for administration.
  • Composition A may advantageously further comprise one or more compounds selected from the group consisting of folic acid, p-aminobenzoic acid, choline, inositol, citrus bioflavonoids, pycnogenol, lipoic acid, coenzyme Q10, proanthocyanidine, dimethyl- aminoethanol and nordihydroguarese acid, in a suitable form for administration.
  • Composition B further comprises one or more of the minerals borium, calcium, iodine, lithium, magnesium, molybdenum, rubidium, selenium, strontium, vanadium, iron and zinc, in a suitable form for administration.
  • Composition B may further advantageously comprise taurin and/or tocotrienol, in a suitable form for administration.
  • compositions A and B are not very critical and can be easily determined experimentally by a person skilled in the art, preferably taking into account factors such as the specific needs (or deficiencies) of individuals to whom the vitamin preparations according to the invention are intended, and the age and the weight of these persons.
  • Suitable amounts of the components for the compositions A and B and possible further compositions, forming part of the dietary supplement composition according to the present invention are for an effective daily oral dose preferably within the ranges shown in Table 1 below: water Vitamin C (Calcium Ascorbate ) 50 - 1 ,000 mg water Vitamin B-l (Thiamin) 0.7 - 100 mg water Vitamin B-2(Riboflavine) 0.8 - 100 mg water Vitamin B-3(Niacinamide ⁇ Niacine) 9 - 100 mg water Vitamin B-5(Calcium Pantothenate) 5 - 300 mg water Vitamin B-6(Pyridoxal 5-Fosfate) 0.7 - 150 mg water Vitamin B-12(Cyanocobalamine) 1 - 100 meg water Vitamin B-15(Pangaam acid) 10 - 150 mg water Vitamin H (Biotine) 0.15 - 300 meg water Folic acid 50 - 800 meg water Para-aminobenzoic acid (PABA) 15 - 100 mg water Choline (
  • the dietary supplement compositions according to the invention may be adapted as far as the composition is concerned to specific target groups (modules).
  • modules are for example described in U.S. Patent No. 5,976,568, the content of which is herein incorporated by reference.
  • Very suitable, typical basis formulations of a dietary supplement composition according to the invention are for example illustrated in Examples 1 and 2. Other more specific modules are also illustrated in the Examples.
  • compositions according to the invention may also be advantageously administered to animals, in particular mammals and especially to pets, such as cats and dogs.
  • animals in particular mammals and especially to pets, such as cats and dogs.
  • the amounts of the compositions A and B mentioned above usually deviate somewhat from the compositions which are taken by humans, but they can be easily optimized by persons skilled in the art based on the present disclosure and their professional skill and knowledge.
  • compositions according to the present invention may be prepared in a known manner for the skilled person.
  • compositions A and B may be administered in various pharmaceutical forms which are known per se, the oral administration being preferred.
  • the preparations may be adminstered both in solid and liquid form, preferably in unit dose form, which forms and dosages are fully known to persons skilled in the art.
  • Suitable solid forms are inter alia capsules, tablets, powders, pastilles and dragees; marikte vloeibare vormen are for example aqueous solutions of the compositions A and B, respectively, in powder form or sirups.
  • the present dietary supplement compositions may be advantageously applied for a plurality of indications, such as, for example, the improvement of the total health and condition of human or animal, to early ageing, improvement of the skin, hair and nails, improvement of the stamina, to smoking and/or use of alcohol, to physical and mental stress, for performing well, optimizing the blood quality, to "ups and downs", to periods of fatigue, to absent-mindedness, stimulating muscle-formation, supplementing and formation of building materials, lowering and control of the level of cholesterol, stimulating the healing of sports and other injuries, excessive exposure to sunshine, optimizing the physical energy, and control of body weight.
  • indications such as, for example, the improvement of the total health and condition of human or animal, to early ageing, improvement of the skin, hair and nails, improvement of the stamina, to smoking and/or use of alcohol, to physical and mental stress, for performing well, optimizing the blood quality, to "ups and downs", to periods of fatigue, to absent-mindedness, stimulating muscle-formation, supplementing and formation of building materials
  • Example 1 A basis dietary supplement composition according to the invention was prepared using the following two compositions:
  • composition A Composition A
  • a capsule contains the following ingredients:
  • Vitamin C (calcium ascorbate) 300 mg
  • Vitamin B-2 (Riboflavine) 25 mg Vitamin B-3 (Niacinamide/Niacine) 50 mg
  • Vitamin B-5 (Calcium Pantothenate) 50 mg
  • Vitamin B-6 (Pyridoxal 5-Phosphate) 25 mg
  • Vitamin B-12 (Cyanocobaltamine) 50 meg
  • Vitamin B-15 (Pangamic acid) 25 mg Vitamin H (Biotin) 100 meg
  • PABA Para-aminobenzoic acid
  • Citrus Bioflavonoids 75 mg Pycnogenol 20 mg Lipoic acid 5 mg Coenzyme Q10 30 mg Proanthocyanidine (Extract of grapestones) 10 mg DMAE (Dimethyl aminoethanol) 50 mg NDGA (Nordihydroguareseacid) 50 mg Chromium (GTF) 100 meg Potassium (Amino Chelate) 100 mg Copper (Gluconate) 2 mg
  • Composition B A capsule contains the following ingredients:
  • Vitamin A (Palmitate) 2.666 ie ⁇ -Carotene (Provitamin A) 15 mg
  • Vitamin D3 (Cholecalciferol) 200 ie
  • Vitamin E D- -Tocoferol 200 ie Vitamin K1 (Phytonadione) 1 mg
  • Vitamin C (Ascorbyl palmitate) 250 mg
  • Composition A is a energy-rich composition containing water soluble vitamins supplemented with other ingredients and minerals, which are taken in the morning and 5 preferably immediately after breakfast.
  • Composition B is a composition for recuperation of the cells in the rest phase (i.e. during the night), containing fat soluble vitamins, supplemented with other ingredients and mineralen, which are taken in the evening and preferably immediately after dinner.
  • composition 1 is preferably taken in the morning, for example at breakfast, whereas composition B is preferably taken 9-17 hours later, and more preferably immediately after dinner.
  • Example 2 illustrates a basis formulation, as does Example 1 , whereas Examples 3 to 6 illustrate a module for men, women, children from 1 year of age, adults in the age of
  • Vitamin A (Calcium Ascorbate) 300 mg Vitamin A (Palmitate) 2.666 ie water Vitamin B-1 (Thiamine) 25 mg Beta Carotene (Provitamin A) 15 mg water Vitamin B-2 (Riboflavin) 25 mg Vitamin C (Ascorbyl Palmitate) 250 mg water Vitamin B-3 (Niacinamide ⁇ Niacin) 50 mg Vitamin D3 (Cholecalciferol) 200 ie water Vitamin B-5 (Pantothenic Acid) 50 mg Vitamin E (D-Alpha-Tocoferol) 200 ie ⁇ c water Vitamin B-6 (Pyridoxine-5-Phos.) 25 mg Vitamin F ( Unsaturated Fatty Acids) 10 mg water Vitamin B-12 (Cyano Cobaltamine) 25 meg Vitamin Kl (Phytonadione) 1 CD mg
  • Vitamin H 150 meg Tocotrienol 20 mg
  • Coenzyme Q10 30 mg Selenium (L-Selenomethionine) 200 meg c Procyanidine/Proanthocianidine (OPC) 50 mg Strontium (Citrate) 1 mg
  • DMAE Dimethyl aminoethanol
  • Vanadum Ammonium Vanadate
  • NDGA Nedihydroguaretic Acid
  • Iron Feumarate
  • GTF Chromium
  • Vitamin B (Calcium Ascorbate) 250 mg fat Vitamin A (Palmitate) 5.000 ie water Vitamin B-1 (Thiamine) 25 mg fat Beta Carotene (Provitamin A) 10 mg water Vitamin B-2 (Riboflavin) 25 mg fat Vitamin C (Ascorbyl Palmitate) 250 mg water Vitamin B-3 (Niacinamide ⁇ Niacin) 50 mg fat Vitamin D3 (Cholecalciferol) 200 ie water Vitamin B-5 (Pantothenic Acid) 50 mg fat Vitamin E (D-Alpha-Tocoferol) 200 ie water Vitamin B-6 (Pyridoxine-5-Phos.) 25 mg fat Vitamin F ( Unsaturated Fatty Acids water Vitamin B-12 (Colabamin) 50 meg fat Vitamin Kl (Phytonadione) water Vitamin H (Biotin) 100 meg Taurine 30 mg water Tolic Acid 300 meg Tocotrienol 20 mg water Para-Aminobenzoic Acid (PABA) 50 mg
  • Vitamin B-12 Coleabamin
  • Vitamin Kl Coleabamin
  • Vitamin H Biotin
  • DMAE Dimethyl aminoethanol Strontium Strontium (Citrate) 1 mg
  • C NDGA Nedihydroguaretic Acid Vanadum (Ammonium vanadate) 300 meg r Chromium (GTF) 100 meg Iron (Fumarate) 15 mg m Potassium (Amino Acid Chelate) 100 mg Zinc (Citrate) 20 mg to Copper (Gluconate) 2 mg
  • NDGA Nedihydroguaretic Acid Vanadum (Ammonium Vanadate) 20 meg C r Chromium (GTF) 20 meg Iron (Fumarate) 2,5 mg m Potassium (Amino Acid Chelate) 1 mg Zinc (Citrate) 4 mg
  • NDGA Nedihydroguaretic Acid 50 mg Iron (Fumarate) 15 mg C Chromium (GTF) 100 meg Zinc (Citrate) 15 mg m Potassium (Amino Acid Chelate) 150 mg
  • Vitamin B (Calcium Ascorbate) 300 mg fat Vitamin A (Palmitate) 6.000 ie water Vitamin B- 1 (Thiamine) 40 mg fat Beta Carotene (Provitamin A) 15 mg water Vitamin B-2 (Riboflavin) 40 mg fat Vitamin C (Ascorbyl Palmitate) 250 mg water Vitamin B-3 (Niacinamide ⁇ Niacin) 80 mg fat Vitamin D3 (Cholecalciferol) 200 ie water Vitamin B-5 (Calcium Pantothenate) 80 mg fat Vitamin E (D-Alpha-Tocoferol) 400 ie water Vitamin B-6 (Pyridoxine-5-Phos.) 40 mg fat Vitamin F ( Unsaturated Fatty Acids) water Vitamin B-12 (Cyano Cobaltmine) 80 meg fat Vitamin Kl (Phytonadione) 1 mg O c water Vitamin B-15 (Calcium Pangamate) 40 mg Taurine 50 mg
  • Vitamin H (Biotin) 200 meg Tocotrienol 40 mg O water Folic Acid 400 meg Boron (Citrate) 2 mg
  • vitamin preparations according to the invention may be varied in several ways by adding or deleting certain ingredients to or from the compositions

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne une composition de complément alimentaire comprenant au moins deux compositions A et B à prendre à différents moments. La composition A comprend essentiellement des vitamines hydrosolubles et la composition B des vitamines liposolubles. La composition A est une composition riche en énergie, constituée de vitamines hydrosolubles et d'autres ingrédients et minéraux, qui doit être prise le matin, de préférence immédiatement après le petit déjeuner. La composition B est une composition servant à la récupération des cellules dans la phase de repos (par exemple pendant la nuit), constituée de vitamines liposolubles et d'autres ingrédients et minéraux, qui doit être prise le soir, de préférence immédiatement après le dîner. La composition A comprend principalement les vitamines suivantes : vitamine C, vitamine B1, vitamine B2, vitamine B3, vitamine B5, vitamine B6, vitamine B12, vitamine B15 et vitamine H. La composition B comprend principalement les vitamines suivantes : vitamine A, provitamine A, vitamine C, vitamine D3 et vitamine K1.
PCT/NL2002/000197 2001-03-27 2002-03-27 Composition de complement alimentaire WO2002076436A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002241408A AU2002241408A1 (en) 2001-03-27 2002-03-27 Modular system of dietary supplement compositions comprising vitamins
EP20020707347 EP1469746A2 (fr) 2001-03-27 2002-03-27 Composition de complement alimentaire

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1017707 2001-03-27
NL1017707A NL1017707C2 (nl) 2001-03-27 2001-03-27 Vitaminepreparaat.

Publications (2)

Publication Number Publication Date
WO2002076436A2 true WO2002076436A2 (fr) 2002-10-03
WO2002076436A3 WO2002076436A3 (fr) 2003-03-13

Family

ID=19773142

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2002/000197 WO2002076436A2 (fr) 2001-03-27 2002-03-27 Composition de complement alimentaire

Country Status (4)

Country Link
EP (1) EP1469746A2 (fr)
AU (1) AU2002241408A1 (fr)
NL (1) NL1017707C2 (fr)
WO (1) WO2002076436A2 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003079819A1 (fr) * 2002-03-27 2003-10-02 Anglo French Drugs And Industries Ltd. Composition de complement alimentaire et son procede de fabrication
WO2004017766A1 (fr) * 2002-08-23 2004-03-04 Dsm Ip Assets B.V. Nouvelles compositions nutraceutiques composees de biotine
WO2004041257A2 (fr) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Compositions neutracetiques comprenant du gallate d'epigallocatechine
FR2859104A1 (fr) * 2003-08-29 2005-03-04 Saint Laurent Parfums Molecules a activite anti-adipogenique sur cellules adipocytaires humaines
EP1541041A1 (fr) * 2003-12-10 2005-06-15 Synergia Holding Compositions pharmaceutiques et/ou diététiques contre le stress
EP1656148A1 (fr) * 2003-08-21 2006-05-17 Duchesnay Inc. Supplement de micronutriment
US7354914B2 (en) 2000-06-01 2008-04-08 Bristol-Myers Squibb Pharma Company Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
WO2008064297A1 (fr) * 2006-11-21 2008-05-29 The Coca-Cola Company Boisson nutritive pour une santé osseuse optimale
EP2135621A1 (fr) * 2008-06-18 2009-12-23 Roberto Fasani Formulations combinées pour le traitement de l'infertilité masculine
US20110177010A1 (en) * 2007-11-27 2011-07-21 Nutri Team Gmbh Vitamin preparation
CN102319263A (zh) * 2011-08-17 2012-01-18 江门市新会区光华生物科技有限公司 一种含多种维生素和矿物质的薄膜包衣片及其制备工艺
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
AT510810A1 (de) * 2010-12-09 2012-06-15 Gonadosan Gmbh Kombinationspräparat zur verbesserung der weiblichen fertilität
JP2013056867A (ja) * 2011-09-09 2013-03-28 Pias Arise Kk 概日リズム調整用キット及び概日リズムの調整方法
WO2014155370A1 (fr) * 2013-03-29 2014-10-02 Omega Pharma Innovation & Development Nv Kit avec suppléments nutritionnels multiples et procédé pour l'assemblage de celui-ci
US20150164825A1 (en) * 2008-06-03 2015-06-18 John Ray Biffin Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436459A (en) * 1963-11-01 1969-04-01 Hoffmann La Roche Fat soluble vitamin compositions
US5514382A (en) * 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
EP0799579A1 (fr) * 1996-04-05 1997-10-08 Jean-Jacques Goupil Complement alimentaire
EP0820703A1 (fr) * 1996-07-22 1998-01-28 Valpharma S.A. Compositions pour intégration nutritionelle comprenant des vitamines hydrosolubles à libération prolongée
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
US5906833A (en) * 1995-05-22 1999-05-25 Klatz; Ronald M. Chronological food bar
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
WO2000030477A1 (fr) * 1998-11-19 2000-06-02 Norbert Fuchs Boisson pour augmenter la capacite a degrader l'alcool
WO2001043571A1 (fr) * 1999-12-14 2001-06-21 Scott Conrad Hohulin Systeme de complement dietetique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59152327A (ja) * 1983-02-16 1984-08-31 Otsuka Pharmaceut Co Ltd 安定な静注用総合ビタミン製剤

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3436459A (en) * 1963-11-01 1969-04-01 Hoffmann La Roche Fat soluble vitamin compositions
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
US5514382A (en) * 1994-10-17 1996-05-07 Sultenfuss; Sherry Daily vitamin and mineral supplement for women
US5906833A (en) * 1995-05-22 1999-05-25 Klatz; Ronald M. Chronological food bar
US5948443A (en) * 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
EP0799579A1 (fr) * 1996-04-05 1997-10-08 Jean-Jacques Goupil Complement alimentaire
EP0820703A1 (fr) * 1996-07-22 1998-01-28 Valpharma S.A. Compositions pour intégration nutritionelle comprenant des vitamines hydrosolubles à libération prolongée
US5976568A (en) * 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
WO2000030477A1 (fr) * 1998-11-19 2000-06-02 Norbert Fuchs Boisson pour augmenter la capacite a degrader l'alcool
WO2001043571A1 (fr) * 1999-12-14 2001-06-21 Scott Conrad Hohulin Systeme de complement dietetique

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch, Week 198441 Derwent Publications Ltd., London, GB; Class A96, AN 1984-253081 XP002224428 & JP 59 152327 A (OTSUKA PHARM CO LTD), 31 August 1984 (1984-08-31) *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7354914B2 (en) 2000-06-01 2008-04-08 Bristol-Myers Squibb Pharma Company Lactams substituted by cyclic succinates as inhibitors of Aβ protein production
WO2003079819A1 (fr) * 2002-03-27 2003-10-02 Anglo French Drugs And Industries Ltd. Composition de complement alimentaire et son procede de fabrication
WO2004017766A1 (fr) * 2002-08-23 2004-03-04 Dsm Ip Assets B.V. Nouvelles compositions nutraceutiques composees de biotine
WO2004041257A2 (fr) * 2002-11-07 2004-05-21 Dsm Ip Assets B.V. Compositions neutracetiques comprenant du gallate d'epigallocatechine
WO2004041257A3 (fr) * 2002-11-07 2004-08-05 Dsm Ip Assets Bv Compositions neutracetiques comprenant du gallate d'epigallocatechine
JP2007533607A (ja) * 2003-08-21 2007-11-22 デュシェネ インク 微量栄養素サプリメント
EP1656148A1 (fr) * 2003-08-21 2006-05-17 Duchesnay Inc. Supplement de micronutriment
EP1656148A4 (fr) * 2003-08-21 2011-07-20 Duchesnay Inc Supplement de micronutriment
WO2005023234A1 (fr) * 2003-08-29 2005-03-17 Yves Saint Laurent Parfums Utilisation de l’acide nor-dihydroguaiaretique en tant qu’inhibiteur de la formation adipocytaire humaine
FR2859104A1 (fr) * 2003-08-29 2005-03-04 Saint Laurent Parfums Molecules a activite anti-adipogenique sur cellules adipocytaires humaines
EP1541041A1 (fr) * 2003-12-10 2005-06-15 Synergia Holding Compositions pharmaceutiques et/ou diététiques contre le stress
FR2863497A1 (fr) * 2003-12-10 2005-06-17 Synergia Holding Nouvelles compositions pharmaceutiques et/ou dietetiques contre le stress
WO2008064297A1 (fr) * 2006-11-21 2008-05-29 The Coca-Cola Company Boisson nutritive pour une santé osseuse optimale
US20110177010A1 (en) * 2007-11-27 2011-07-21 Nutri Team Gmbh Vitamin preparation
US20150164825A1 (en) * 2008-06-03 2015-06-18 John Ray Biffin Method for increasing bone density and/or reducing any osteochondral defects in an animal and a composition including vitamin k
EP2135621A1 (fr) * 2008-06-18 2009-12-23 Roberto Fasani Formulations combinées pour le traitement de l'infertilité masculine
AT510810A1 (de) * 2010-12-09 2012-06-15 Gonadosan Gmbh Kombinationspräparat zur verbesserung der weiblichen fertilität
AT510810B1 (de) * 2010-12-09 2017-09-15 Gonadosan Gmbh Kombinationspräparat zur verbesserung der weiblichen fertilität
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
CN102319263A (zh) * 2011-08-17 2012-01-18 江门市新会区光华生物科技有限公司 一种含多种维生素和矿物质的薄膜包衣片及其制备工艺
JP2013056867A (ja) * 2011-09-09 2013-03-28 Pias Arise Kk 概日リズム調整用キット及び概日リズムの調整方法
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
US8545896B2 (en) 2011-09-29 2013-10-01 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
WO2014155370A1 (fr) * 2013-03-29 2014-10-02 Omega Pharma Innovation & Development Nv Kit avec suppléments nutritionnels multiples et procédé pour l'assemblage de celui-ci

Also Published As

Publication number Publication date
NL1017707C2 (nl) 2002-10-01
AU2002241408A1 (en) 2002-10-08
EP1469746A2 (fr) 2004-10-27
WO2002076436A3 (fr) 2003-03-13

Similar Documents

Publication Publication Date Title
Akram et al. Vitamins and Minerals: Types, sources and their functions
US7238373B2 (en) Nutritional supplement
WO2002076436A2 (fr) Composition de complement alimentaire
Bellows et al. Water-soluble vitamins: B-complex and vitamin C
Chandra Graying of the immune system: can nutrient supplements improve immunity in the elderly?
Nielsen Boron in human and animal nutrition
US5932624A (en) Vitamin supplement composition
US7887847B2 (en) Nutritional supplement for treatment of ocular diseases
US8197854B2 (en) Nutritional supplement for use under physiologically stressful conditions
US10842839B2 (en) Natural formulation for treating hangover
US9498434B2 (en) Dissolvable dietary supplement strip and methods for using the same
US20130017182A1 (en) Multi-criteria optimized dietary supplement formulations
Salwen Vitamins and trace elements
JP2002051732A (ja) 食事による植物性化学物質欠乏症を矯正する組成物及び方法
US20090011048A1 (en) Dietary Supplement For Promoting Removal Of Heavy Metals From The Body
US20130101569A1 (en) Hair growth stimulant
AU2021204218A1 (en) Hair Restorer Preparation Or Food Supplement
RU2665635C2 (ru) Мультивитаминная/минеральная композиция для борьбы с эффектами экологического стресса; повышения иммунитета и повышения активности, направленная на недостаточности витаминов и минералов без негативных побочных эффектов мегадозовой пищевой добавки
US20060182729A1 (en) Combat/training antioxidant micronutrient formulation and method of administration
Leutholtz et al. Optimizing nutrition for exercise and sport
Ebuehi et al. Effect of zinc deficiency on memory, oxidative stress and blood chemistry in rats
Jackson et al. Nutritional requirements of infants and children
US20170245533A1 (en) Fortified Micronutrient Product and Methods of Use and Manufacture
Padh Vitamins for optimal health
Morcos et al. Effect of vitamin C and carotene on the absorption of calcium from the intestine

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

WWE Wipo information: entry into national phase

Ref document number: 2002707347

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 2002707347

Country of ref document: EP

NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2002707347

Country of ref document: EP